Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Enteral Feeding Formulas Market

Enteral Feeding Formulas Market Size

Report ID: GMI12131
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Enteral Feeding Formulas Market Size

The global enteral feeding formulas market size was valued at around USD 7 billion in 2023 and is estimated to grow at 7.1% CAGR from 2024 to 2032. Enteral feeding formulas are liquid nutritional products crafted to nourish individuals unable to eat orally due to medical issues, including swallowing difficulties, gastrointestinal disorders, or specific neurological conditions. These formulas are administered via a feeding tube, directly targeting the stomach or small intestine.

To get key market trends

Download Free Sample

As chronic diseases like cancer, stroke, multiple sclerosis, dementia, chronic liver disease, COPD, and diabetes become more prevalent, the demand for solutions to oral intake challenges is set to rise. The International Diabetes Federation (IDF) forecasts a surge in the adult diabetes population, from 537 million in 2021 to 643 million by 2030, and reaching 783 million by 2045.

Additionally, dietary management for sarcopenia—a condition in older adults marked by reduced muscle strength—often incorporates enteral foods. A December 2022 study in BioMed Central highlighted that sarcopenia affects 1-29% of older adults, with heightened prevalence in long-term care settings. The research underscored a link between malnutrition and sarcopenia, noting that malnourished individuals face a greater risk. Given this, and the swift growth of the elderly demographic alongside rising age-related medical conditions, the market is poised for significant expansion.

Furthermore, the global preterm birth rate, as reported by the World Health Organization (WHO), stands between 5-18% of all births, underscoring the rising demand for sip feeds tailored to newborns. Compounding this demand is the escalating issue of nutritional deficiencies—especially in infants and pregnant women—highlighting shortages in vital micronutrients, proteins, and other essential nutrients.

Enteral Feeding Formulas Market Report Attributes
Report Attribute	Details
Base Year:	2023
Enteral Feeding Formulas Market Size in 2023:	USD 7 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	7.1%
2024 – 2032 Value Projection:	USD 12.9 Billion
Historical Data for:	2021 – 2023
No. of Pages:	150
Tables, Charts & Figures:	185
Segments covered:	Product, Stage, Application, End Use, and Region
Growth Drivers:	Rising geriatric population and chronic disease prevalence Growing demand for neonatal and preterm enteral feeding Increasing demand for enteral feeding in home care settings Shifting trend toward consumption of disease-specific formulas
Pitfalls & Challenges:	High costs associated with enteral feeding Risk of complications

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global enteral feeding formulas industry was valued at approximately USD 7 billion in 2023 and is estimated to grow at a 7.1% CAGR from 2024 to 2032, driven by the increasing prevalence of medical conditions requiring enteral nutrition.

The standard formulas market generated USD 3.6 billion in 2023 and is expected to grow due to their widespread adoption across diverse patient groups and cost-effectiveness.

The U.S. enteral feeding formulas industry was valued at USD 2.8 billion in 2023 and is projected to grow at a CAGR of 7.2% over the forecast period, supported by innovations in product formulations such as lactose-free and gluten-free options.

Key players in the industry include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Danone S.A., Fresenius Kabi, Functional Formularies, Hormel Health Labs, Kate Farms, Medtrition, and Meiji Holdings.